The Safety of Intrathecal Therapy in the Treatment of Immune Effector Cell-Associated Neurotoxicity Syndrome (ICANS)Phavina A Akhom, Adetola A. Kassim, Vivek Patel et al.|Transplantation and Cellular Therapy|2025Cited by 2
Brexucabtagene Autoleucel in the Outpatient Setting, a Single Institution ExperienceDavid Morgan, Phavina A Akhom, Brian Hoeynck et al.|Transplantation and Cellular Therapy|2025Cited by 0